Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Argent Biopharma ( (AU:RGT) ) has issued an announcement.
Argent Biopharma Limited announced the issuance of 3,300,000 convertible notes and 21,950,952 unlisted options exercisable at A$0.1025, expiring on December 3, 2028. This move is part of a previously announced transaction and reflects the company’s strategic efforts to strengthen its financial position and enhance its market operations.
More about Argent Biopharma
Argent Biopharma Limited operates in the biotechnology industry, focusing on the development and commercialization of pharmaceutical products.
Average Trading Volume: 87,148
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.91M
See more insights into RGT stock on TipRanks’ Stock Analysis page.